Malaysia medical tourism 2026: the Penang and Kuala Lumpur contest with Thailand
Cluster competitiveness, the cost-quality frontier against Bangkok, and the path to a RM12 billion healthcare-travel economy by 2030.
Executive summary
Malaysia is Southeast Asia's second-largest medical tourism destination after Thailand, receiving approximately 1.1 million medical tourist arrivals in 2024 and generating $1.8 billion in healthcare services revenue from foreign patients. The competitive advantage rests on internationally accredited hospitals, English-language capability, and price points 40–70% below Singapore for comparable procedures. Indonesia accounts for an estimated 60% of inbound medical tourists, primarily from Sumatra accessing Penang's medical cluster. Kuala Lumpur and Penang are the primary medical tourism clusters. This report covers Malaysia's medical tourism market sizing, patient source country breakdown, hospital competitive landscape, specialty procedure mix, pricing benchmarks, Malaysia Healthcare Travel Council strategy, and the growth outlook through 2026.
Report details
- Published
- 2026-06-08
- Pages
- 18
- Format
- Code
- MY-HLT-XPL-D26-01
- Market
- Malaysia
- Industry
- Medical Tourism
- Year
- 2026
Table of contents · 15 sections
- 01 Executive summary — the state of play
- 02 Strategic implications — five reads
- 03 The demand engine — chapter
- 04 Market sizing & trajectory
- 05 Where the patients come from
- 06 Two clusters, two playbooks — chapter
- 07 The Penang cluster
- 08 The Kuala Lumpur cluster
- 09 The contest with Thailand — chapter
- 10 Benchmarking Bangkok
- 11 The cost-quality frontier
- 12 Digital and AI in patient care
- 13 Outlook to 2030
- 14 Strategic implications by stakeholder
- 15 Methodology & sources
The full report is available to subscribers and buyers. The executive summary above is free to read.